All News

Association between cannabis use disorder and schizophrenia stronger in young males than in females

Published online by Cambridge University Press:  04 May 2023 Carsten Hjorthøj[, Wilson Compton, Marie Starzer, Dorte Nordholm ,Emily Einstein, Annette Erlangsen, Merete Nordentoft ,Nora D. Volkow and Beth Han Abstract Background Previous research suggests an increase in schizophrenia population attributable risk fraction (PARF) for cannabis use disorder (CUD). However, sex and age variations in CUD and schizophrenia

Read More »

The association between reasons for first using cannabis, the later pattern of use, and risk of First-Episode psychosis: the Eu-gei cases control study

Edoardo Spinazzola1,* , Diego Quattrone2,3,4,* , Victoria Rodriguez1, Giulia Trotta2 , Luis Alameda1,5,6 , Giada Tripoli1,7 ,Charlotte Gayer-Anderson8 , Tom P Freeman9,10, Emma C Johnson11, Hannah E Jongsma12, Simona Stilo1,13, Caterina La Cascia7, Laura Ferraro7, Daniele La Barbera7, Antonio Lasalvia14, Sarah Tosato14, Ilaria Tarricone15, Giuseppe D’Andrea15, Michela Galatolo15, Andrea Tortelli16,17,Ilaria Tagliabue18,19, Marco Turco18, Maurizio Pompili20,

Read More »

Young men at highest risk of schizophrenia linked with cannabis use disorder

NIH study highlights the need to proactively screen for, prevent, and treat cannabis use disorder, especially among young people May 4, 2023 ©Getty Images/Nikola Stojadinovic Young men with cannabis (marijuana) use disorder have an increased risk of developing schizophrenia, according to a study led by researchers at the Mental Health Services in the Capital Region of

Read More »

Listen to podcast High Truths on Drugs and Addiction on your favorite platform. ​

Most Recent News

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Read More »

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Read More »

IASIC Speaker Series Presents: Case Report on Cannabis-Induced Acute Encephalopathy in Elderly After Taking CBD

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Read More »
Scroll to Top